Cargando…
From strict moral standards to ethical neutrality: a policy-guided shift in the patentability of human embryonic stem cells in China
Attitudes towards human embryonic stem cells (hESCs) in China have witnessed a significant shift in 2020 that can be attributed to China’s policy guidance. For ethical reasons, stricter standards are adopted to curb related regulations and patent licensing. Through the introduction of policies, some...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687789/ https://www.ncbi.nlm.nih.gov/pubmed/33239089 http://dx.doi.org/10.1186/s13287-020-02013-x |